Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Int. braz. j. urol ; 45(3): 621-628, May-June 2019. tab, graf
Article in English | LILACS | ID: biblio-1012317

ABSTRACT

Abstract Purpose: To investigate the relationship between 25-hydroxyvitamin D (25 (OH) D) levels and acquired premature ejaculation (PE). Materials and Methods: A total of 97 patients with acquired PE and 64 healthy men as a control group selected from volunteers without PE attending our Andrology Outpatient Clinic between November 2016 and April 2017 were included the study. All patients were considered to have acquired PE if they fulfilled the criteria of the second Ad Hoc International Society for Sexual Medicine Committee. Premature ejaculation diagnostic tool questionnaires were used to assessment of PE and all participants were instructed to record intravaginal ejaculatory latency time. Vitamin D levels were evaluated in all participants using high performance liquid chromatography method included in the study. Results: Compared to men without PE, the patients with acquired PE had significantly lower 25 (OH) D levels (12.0 ± 4.5 ng/mL vs. 18.2 ± 7.4 ng/mL, p < 0.001). In the logistic regression analysis, 25 (OH) D was found to be an independent risk factor for acquired PE, with estimated odds ratios (95% CI) of 0.639 (0.460-0.887, p = 0.007) and the area under curve of the ROC curve of 25 (OH) D diagnosing acquired PE was 0.770 (95% CI: 0.695 to 0.844, p < 0.001). The best cut-off value was 16 ng/mL with a sensitivity of 60.9%, specificity of 83.5%, PPV of 70.9%, and NPV of 76.4% to indicate acquired PE. Conclusions: This study demonstrates that lower vitamin D levels are associated with the acquired PE. The result of our study showed that the role of serum vitamin D levels should be investigate in the etiology of acquired PE. Perhaps supplementation of vitamin D in men with acquired PE will ameliorate the sexual health of these patients.


Subject(s)
Humans , Male , Adult , Young Adult , Vitamin D/analogs & derivatives , Vitamin D Deficiency/complications , Vitamin D Deficiency/blood , Premature Ejaculation/etiology , Premature Ejaculation/blood , Testosterone/blood , Vitamin D/blood , Case-Control Studies , Logistic Models , Multivariate Analysis , Predictive Value of Tests , Prospective Studies , Surveys and Questionnaires , Risk Factors , ROC Curve , Middle Aged
2.
Int. braz. j. urol ; 44(2): 288-295, Mar.-Apr. 2018. tab
Article in English | LILACS | ID: biblio-892984

ABSTRACT

ABSTRACT Purpose To assess the relationship between De Ritis (aspartate aminotransaminase [AST]/Alanine aminotransaminase [ALT]) ratio and pathological variables and whether it is an independent prognostic factor. Materials and Methods We analyzed 298 consecutive patients who underwent radical or partial nephrectomy for non-metastatic renal cell carcinoma (RCC) between 2006 and 2015. The association between De Ritis ratio and pathological variables including tumor size, presence of renal vein invasion, vena cava invasion, renal capsule infiltration, Gerota fascia invasion, renal sinus involvement, renal pelvic invasion, angiolymphatic invasion, adrenal gland involvement, lymph node involvement, tumor necrosis, and Fuhrman's grade was tested. Multivariable Cox analysis was performed to evaluate the impact of this ratio on overall survival and cancer-specific survival. Results An increased preoperative De Ritis ratio was significantly associated with renal vein invasion, renal capsule infiltration and renal pelvis involvement (p<0.05) in non-metastatic RCC. On multivariate analysis we found that tumor size, Fuhrman grade and lymph node involvement were independent prognostic factors for cancer-specific survival. AST/ALT ratio had no influence on the risk of overall and cancer-specific survival. Conclusion An increased preoperative AST/ALT ratio had a significant association with renal vein invasion, renal capsule infiltration and renal pelvis involvement in patients with non-metastatic RCC. However, it does not appear to be an independent prognostic marker in non-metastatic RCC.


Subject(s)
Humans , Male , Female , Adult , Aged , Aspartate Aminotransferases/blood , Carcinoma, Renal Cell/enzymology , Alanine Transaminase/blood , Kidney Neoplasms/enzymology , Carcinoma, Renal Cell/mortality , Carcinoma, Renal Cell/pathology , Biomarkers, Tumor/blood , Survival Analysis , Kidney Neoplasms/mortality , Kidney Neoplasms/pathology , Middle Aged , Neoplasm Invasiveness , Neoplasm Staging
3.
Int. braz. j. urol ; 43(2): 311-316, Mar.-Apr. 2017. tab
Article in English | LILACS | ID: biblio-840823

ABSTRACT

ABSTRACT Purpose Premature ejaculation is considered the most common type of male sexual dysfunction. Hormonal controls of ejaculation have not been exactly elucidated. The aim of our study is to investigate the role of hormonal factors in patients with premature ejaculation. Materials and Methods Sixty-three participants who consulted our outpatient clinics with complaints of premature ejaculation and 39 healthy men as a control group selected from volunteers were included in the study. A total of 102 sexual active men aged between 21 and 76 years were included. Premature ejaculation diagnostic tool questionnaires were used to assessment of premature ejaculation. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, total and free testosterone, thyroid-stimulating hormone, free triiodothyronine and thyroxine were measured. Results Thyroid-stimulating hormone, luteinizing hormone, and prolactin levels were significantly lower in men with premature ejaculation according to premature ejaculation diagnostic tool (p=0.017, 0.007 and 0.007, respectively). Luteinizing hormone level (OR, 1.293; p=0.014) was found to be an independent risk factor for premature ejaculation. Conclusions Luteinizing hormone, prolactin, and thyroid-stimulating hormone levels are associated with premature ejaculation which was diagnosed by premature ejaculation diagnostic tool questionnaires. The relationship between these findings have to be determined by more extensive studies.


Subject(s)
Humans , Male , Adult , Aged , Young Adult , Premature Ejaculation/blood , Hormones/blood , Reference Values , Biomarkers/blood , Case-Control Studies , Prospective Studies , Surveys and Questionnaires , Risk Factors , Statistics, Nonparametric , Premature Ejaculation/etiology , Premature Ejaculation/physiopathology , Hyperthyroidism/complications , Hyperthyroidism/physiopathology , Middle Aged
4.
Int. braz. j. urol ; 39(4): 465-473, Jul-Aug/2013. tab
Article in English | LILACS | ID: lil-687294

ABSTRACT

Introduction The correlation between erectile dysfunction (ED) and coronary artery disease has been emphasized and ED has been recognized as a potential independent risk factor and/or predictor of coronary artery disease (CAD). We evaluated the association between the number of occluded coronary arteries in myocardial infarction (MI) patients with the severity of ED, and investigated the influence of related risk factors in our study group. Materials and Methods 183 male patients who underwent coronary angiography because of acute MI from November 2009 to May 2011 were included. Following the stabilization of patients after the treatment, each patient was evaluated for erectile functionality. Risk factors such as age, diabetes, smoking, waist circumference, hypertension, and hematologic parameters were recorded. Results Among 183 patients with a mean age of 55.2 years who underwent coronary angiography due to acute MI, 100 (54.64%) had ED, while the ED rate was 45.36% (44/97) in cases of single-vessel disease, 64.5% (31/48) in cases of two-vessel disease, and 65.7% (25/38) in cases of three-vessel disease. The mean IIEF score was 24.2 ± 4.3, 20.4 ± 4.9 and 20.5 ± 4.2 for single or two or three-vessel disease, respectively. The presence of hypertension aggravated ED only in patients with three-vessel disease and increased total and LDL cholesterol levels in patients with single-vessel or two-vessel disease were accompanied by significantly decreasing IIEF scores. Conclusion The severity of ED correlated with the number of occluded vessels documented by coronary angiography, in male patients with acute myocardial infarction. In addition, the presence of hypertension had a significant influence over erectile function only in patients with three-vessel occlusion. .


Subject(s)
Adult , Aged , Humans , Male , Middle Aged , Coronary Artery Disease/complications , Erectile Dysfunction/complications , Myocardial Infarction/complications , Severity of Illness Index , Age Distribution , Coronary Angiography , Coronary Artery Disease/epidemiology , Coronary Occlusion , Erectile Dysfunction/epidemiology , Hypertension/complications , Hypertension/epidemiology , Myocardial Infarction/epidemiology , Risk Factors , Statistics, Nonparametric , Waist Circumference
5.
Int. braz. j. urol ; 37(2): 195-202, Mar.-Apr. 2011. graf, tab
Article in English | LILACS | ID: lil-588992

ABSTRACT

PURPOSE: To evaluate hyoscine N-butyl bromide (HBB) and three different alpha-1 blockers in the treatment of distal ureteral stones. MATERIALS AND METHODS: A total of 140 patients with stones located in the distal tract of the ureter with stone diameters of 5 to 10mm were enrolled in the present study and were randomized into 4 equal groups. Group 1 received HBB, Group 2 received alfuzosin, Group 3 received doxazosin and Group 4 received terazosin. The subjects were prescribed diclofenac injection (75 mg) intramuscularly on demand for pain relief and were followed-up after two weeks with x-rays of the kidneys, ureters, bladder and urinary ultrasonography every week. The number of pain episodes, analgesic dosage and the number of days of spontaneous passage of the calculi through the ureter were also recorded. RESULTS: The average stone size for groups 1, 2, 3 and 4 was comparable (6.13, 5.83, 5.59 and 5.48 mm respectively). Stone expulsion was observed in 11 percent, 52.9 percent, 62 percent, and 46 percent in groups 1, 2, 3 and 4 respectively. The average time to expulsion was 10.55 ± 6.21 days in group 1, 7.38 ± 5.55 days in group 2, 7.85 ± 5.11 days in group 3 and 7.45 ± 5.32 days in group 4. Alpha blockers were found to be superior to HBB (p < 0.05). CONCLUSIONS: Medical treatment of distal ureteral calculi with alfuzosin, doxazosin and terazosin resulted in a signi?cantly increased stone-expulsion rate and decreased expulsion time when compared with HBB. HBB seems to have a negative effect on stone-expulsion rate.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Adrenergic alpha-1 Receptor Antagonists/therapeutic use , Butylscopolammonium Bromide/therapeutic use , Doxazosin/therapeutic use , Prazosin/analogs & derivatives , Quinazolines/therapeutic use , Ureteral Calculi/drug therapy , Prospective Studies , Prazosin/therapeutic use , Treatment Outcome
6.
Int. braz. j. urol ; 37(1): 79-86, Jan.-Feb. 2011. ilus
Article in English | LILACS | ID: lil-581540

ABSTRACT

PURPOSE: To investigate whether the use of a disposable needle guide results in a decreased incidence of infectious complication after transrectal prostate needle biopsy (TPNB). MATERIALS AND METHODS: Fifty five patients who underwent 10-core TPNB were randomized into two groups. A pre-biopsy blood and urine examination was performed in both groups. Group 1 (25 patients) underwent biopsy with disposable biopsy needle guide and Group 2 (30 patients) underwent biopsy with reusable biopsy needle guide. All patients had a blood and negative urine culture before the procedure. The patients received ciprofloxacin 500 mg twice a day beginning the day before the biopsy and continued for 3 days after. Serum C-reactive protein levels and urine and blood specimens were obtained 48h after the biopsy. Primary endpoint of the study was to determine the effect of needle guide on the bacteriologic urinary tract infection (UTI) rate and secondary end point was to determine symptomatic UTI. RESULTS: The mean age of the patients was 63.46 (range 55 to 68) years. There were no significant differences regarding the prostate-specific antigen level, prostate size, existence of comorbidity in two groups before the procedure. Bacteriologic and symptomatic UTI was detected in 4 percent vs. 6.6 percent and 4 percent vs. 3.9 percent in Group 1 and 2 relatively (P > 0.05). CONCLUSION: The use of a disposable needle guide does not appear to minimize infection risk after TPNB. Large scale and randomized studies are necessary to determine the effect of disposable needle guide on infection rate after TPNB.


Subject(s)
Aged , Humans , Male , Middle Aged , Biopsy, Needle/instrumentation , Disposable Equipment , Infection Control/methods , Postoperative Complications/prevention & control , Prostate/pathology , Analysis of Variance , Biopsy, Needle/adverse effects , Biopsy, Needle/methods , Chi-Square Distribution , Infections , Predictive Value of Tests , Prospective Studies , Prostate/surgery , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL